Petosemtamab, a Bispecific Antibody Targeting Epidermal Growth Factor Receptor (EGFR) and Leucine-Rich G Repeat-Containing Protein-Coupled Receptor (LGR5) Designed for Broad Clinical Applications.
- Published in:
- Cancers, 2025, v. 17, n. 10, p. 1665, doi. 10.3390/cancers17101665
- By:
- Publication type:
- Article